# High Dose Ascorbic Acid Treatment of CMT1A

> **NCT00484510** · PHASE2,PHASE3 · COMPLETED · sponsor: **Wayne State University** · enrollment: 110 (actual)

## Conditions studied

- Charcot-Marie-Tooth Disease, Type Ia

## Interventions

- **DRUG:** Ascorbic acid (Vitamin C)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00484510
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2013-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00484510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00484510, "High Dose Ascorbic Acid Treatment of CMT1A". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00484510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*